According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -2,45ย โฌ. In 2024 the company made an earnings per share (EPS) of -3,36ย โฌ an increase over its 2023 EPS that were of -5,19ย โฌ.